| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 34.779 | 31.513 | 30.192 | 38.388 | 37.710 | 23.636 | 34.870 | 48.542 | 58.972 | 53.664 |
| Total Income - EUR | 35.327 | 32.595 | 30.208 | 38.398 | 37.725 | 24.344 | 34.885 | 48.563 | 59.034 | 53.735 |
| Total Expenses - EUR | 26.633 | 23.035 | 23.965 | 21.939 | 22.391 | 23.868 | 25.892 | 27.328 | 32.678 | 32.019 |
| Gross Profit/Loss - EUR | 8.694 | 9.560 | 6.243 | 16.459 | 15.334 | 475 | 8.992 | 21.235 | 26.356 | 21.717 |
| Net Profit/Loss - EUR | 7.650 | 9.245 | 5.941 | 16.076 | 14.961 | 258 | 8.648 | 20.755 | 25.766 | 20.107 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Medifrance Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 822 | 1.221 | 891 | 590 | 386 | 1.195 |
| Current Assets | 30.016 | 41.898 | 24.666 | 32.288 | 44.272 | 43.434 | 51.594 | 72.975 | 101.900 | 123.169 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 135 | 0 |
| Receivables | 79 | 161 | 114 | 2.669 | 2.516 | 221 | 4.488 | 1.428 | 9.357 | 20.107 |
| Cash | 29.936 | 41.737 | 24.552 | 29.620 | 41.756 | 43.213 | 47.106 | 71.547 | 92.408 | 103.062 |
| Shareholders Funds | 22.536 | 31.551 | 5.994 | 21.960 | 36.496 | 36.062 | 44.784 | 61.623 | 87.202 | 103.243 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 7.480 | 10.346 | 18.672 | 10.328 | 8.599 | 8.593 | 7.700 | 11.942 | 15.085 | 21.121 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medifrance Srl